Receptor Life Sciences Revenue and Competitors
Estimated Revenue & Valuation
- Receptor Life Sciences's estimated annual revenue is currently $804k per year.
- Receptor Life Sciences's estimated revenue per employee is $100,500
Employee Data
- Receptor Life Sciences has 8 Employees.
- Receptor Life Sciences grew their employee count by -50% last year.
Receptor Life Sciences's People
Name | Title | Email/Phone |
---|---|---|
1 | VP, Product Development | Reveal Email/Phone |
2 | VP, Product Development | Reveal Email/Phone |
3 | Founder, CFO And Director | Reveal Email/Phone |
Receptor Life Sciences Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $15.1M | 75 | 19% | N/A | N/A |
#2 | $0.8M | 8 | -50% | N/A | N/A |
#3 | $114M | 567 | 7% | N/A | N/A |
#4 | $19.3M | 96 | 13% | N/A | N/A |
#5 | $5.4M | 27 | 17% | N/A | N/A |
#6 | $17.7M | 88 | -45% | N/A | N/A |
#7 | $13.9M | 69 | 10% | N/A | N/A |
#8 | $5.4M | 27 | -10% | N/A | N/A |
#9 | $0.8M | 8 | 0% | $22M | N/A |
#10 | $5.4M | 27 | 29% | N/A | N/A |
What Is Receptor Life Sciences?
Receptor Life Sciences combines proven drug delivery technologies, compelling therapeutic candidates, and traditional drug development research practices to pursue a robust range of prescription drug treatments for CNS indications. The delivery technologies, used in both oral and inhaled FDA-approved prescription drug products, represent a validated, strategic approach to overcoming traditional challenges of cannabinoid medicine. Receptor’s patented product candidates hold the potential to provide prescription treatments for a range of unmet medical needs, including anxiety and agitation in autism. More information is at www.ReceptorLife.com.
keywords:N/AN/A
Total Funding
8
Number of Employees
$804k
Revenue (est)
-50%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | N/A | 8 | N/A | N/A |
#2 | $0.6M | 8 | N/A | N/A |
#3 | $0.6M | 8 | N/A | N/A |
#4 | $0.6M | 8 | -20% | N/A |
#5 | $1M | 8 | 14% | N/A |